showed a trendp = 0.08
In patients with hepatic dysfunction, the active smoker group showed a trend towards more profound coagulopathy (mean INR 1.3 ± 0.2 vs. 1.2 ± 0.2, p = 0.08). 3.3.
In patients with hepatic dysfunction, the active smoker group showed a trend towards more profound coagulopathy (mean INR 1.3 ± 0.2 vs. 1.2 ± 0.2, p = 0.08). 3.3.